Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, high-yield synthesis for xianglanoside intermediates. Avoid silver catalysts, reduce byproducts, and ensure supply chain stability for cardiovascular drug development.
Overcome riociguat synthesis challenges: 40% yield, <0.05% impurity, and DMF-free process. NINGBO INNO PHARMCHEM delivers GMP-compliant production for your API needs.
Solve explosion risks in dihydrobenzochromene synthesis with this 95%+ yield ruthenium-catalyzed method. Cheap raw materials, scalable to 100kg+ production. Contact for COA/MSDS.
Discover a metal-free, air-stable C2-phosphono indole synthesis method with >99% purity, high atom economy, and scalable production for pharmaceutical applications.
Solve metal residue issues in thioether synthesis with this metal-free, room-temperature method. Achieve 80-93% yields for drug intermediates with no expensive catalysts.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Eliminate CO gas handling risks & reduce costs by 30% with this scalable multi-component synthesis for high-purity pharmaceutical intermediates. Contact us for custom production.
Solve N-aryl imine allylation challenges with this metal-free, air-tolerant process. Achieve 94% yields and eliminate expensive anhydrous equipment. Contact for CDMO scale-up.
Solve N-aryl imine allylation challenges with this metal-free, air-stable method. Achieve 85-94% yields at room temperature, reducing equipment costs and supply chain risks for API synthesis.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.
Solve low-yield & heavy metal issues in ramipril intermediate production. 85-99% purity, 85-99% yield, eco-friendly process. Scale to 100 MT/yr with CDMO expertise.
Solve OAB drug supply chain risks with 4-step metal-free synthesis. 95% yield, no phosphine waste. Reduce production costs by 30%.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Discover how this novel alkylation method reduces production costs by 30% and eliminates hazardous reagents for agrochemical manufacturing.
Solve high-cost synthesis challenges for 5-trifluoromethyl-1,2,4-triazole compounds. Our metal-free, scalable method reduces catalyst costs and supply chain risks for GlyT1 inhibitors.
Solve high-cost, low-yield issues in trifluorostyrene synthesis. Our CDMO leverages patent-validated routes for 92% yield, eliminating toxic reagents and anhydrous conditions. Scale to 100MT/yr.
Discover metal-free synthesis of tetrahydrofuran-quinoline compounds with 65% yield. Eliminate catalyst costs and supply chain risks for pharmaceutical intermediates.
Solve supply chain risks with this metal-free, high-yield synthesis method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production costs by 30%.
Solve supply chain risks with air-atmosphere, metal-free synthesis of trifluoroacetimide-substituted dihydrobenzofuran. High stereoselectivity, low-cost raw materials, and scalable to gram level for pharma R&D and production.
Solve supply chain risks with 85-93% yield 2-hydroxyphenyl sulfide synthesis. CDMO expertise in metal-free catalysis for API manufacturing.